Synopsys, a key software and IP provider for AI chip design, is gaining investor attention with shares trading at $509.26 and a 24/7 Wall St. price target of $632.92, implying a 24.28% upside. The company reported a 42.4% revenue increase in Q3 and raised its full-year guidance, driven by growing demand for complex AI chip design tools. Analysts are bullish, expecting continued double-digit growth and successful integration of Ansys technology, though risks include export controls and debt. Synopsys is valued more attractively compared to peers Cadence and Arm, supporting its buy rating and potential price targets up to $969 by 2030.
Following growing investor interest in AI chip design stocks like Synopsys, the company’s shares are trading at USD 509.99 on Pluang as of Oct 10, 2026 23:41 WIB, up 2.46% for the day. Synopsys holds a market cap of USD 97.73 billion and a 52-week high of USD 534.56. Meanwhile, peers Cadence and Arm trade at USD 352.84 and USD 266.28 respectively, with Cadence up 1.15% and Arm down 3.27% on the same day.
Synopsys, a leader in Electronic Design Automation (EDA) software essential for AI chip production, reported a 42% year-over-year revenue increase in Q3. EDA software now makes up 51.8% of its total revenue, with operating income soaring 116% year-ov...
Synopsys reported strong Q3 results with revenue up 42.4% year-over-year and earnings per share beating estimates for the fourth consecutive quarter. The company raised its full-year earnings and free cash flow guidance, driven by growth in its EDA s...
Synopsys has reported strong earnings beats three times in 2026, with revenue and EPS growth driven by AI design and new product launches. Despite this, the stock has fallen after each earnings report, reflecting investor concerns over its $10 billio...
